drugset
drugset / Trial / NCT06325605

Efficacy and Safety of Bifidobacterium Combined With High-frequency Transcranial Magnetic Stimulation in the Treatment of Adolescent Depression

NCT06325605 ↗

Completed 100 enrolled Zhen-Hong Hu
RandomizedParallel-groupDouble-blindTreatment

Summary

A total of 100 patients with adolescent depression who were admitted to our hospital between March 2022 and October 2022 were selected. On the basis of double blinding, these patients were randomly divided into the observation group(n=50) and the control group(n=50) using a random number table. 5S management method was used in the whole process of treatment to improve the hospital environment, increase the work efficiency and reduce the occurrence of cross infection through the effective implementation of the five steps of sort(Seiri), set in order(Seiton), shine (Seiso), standardize(Seiketsu) and sustain(Shitsuke).

Timeline

Start
2022-03-01
Primary completion
2022-10-31
Completion
2022-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject BIFIDOBACTERIUM SPP. Other / unclassified 0.07 g Oral
Comparator Escitalopram Small molecule 20 mg Oral

Indications

No indication recorded.